Anne Samuel
Stock Analyst at JP Morgan
(1.85)
# 3,235
Out of 5,179 analysts
67
Total ratings
50%
Success rate
-3.32%
Average return
Main Sectors:
Stocks Rated by Anne Samuel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Overweight | $13 → $7 | $2.21 | +216.74% | 13 | Nov 17, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $125 → $126 | $82.51 | +52.71% | 9 | Sep 3, 2025 | |
| VEEV Veeva Systems | Maintains: Neutral | $274 → $290 | $172.59 | +68.03% | 7 | Aug 28, 2025 | |
| PGNY Progyny | Maintains: Neutral | $23 → $25 | $17.27 | +44.76% | 8 | Aug 26, 2025 | |
| DOCS Doximity | Maintains: Neutral | $63 → $60 | $23.69 | +153.27% | 7 | May 27, 2025 | |
| IQV IQVIA Holdings | Maintains: Overweight | $232 → $177 | $163.85 | +8.03% | 7 | May 19, 2025 | |
| OMCL Omnicell | Maintains: Neutral | $44 → $36 | $32.75 | +9.92% | 5 | Mar 20, 2025 | |
| PHR Phreesia | Maintains: Overweight | $27 → $28 | $10.98 | +155.01% | 2 | Sep 9, 2024 | |
| CCSI Consensus Cloud Solutions | Downgrades: Underweight | $19 → $21 | $24.43 | -14.04% | 3 | Sep 9, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $10 → $13 | $1.10 | +1,081.82% | 3 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $23.54 | +14.70% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $7 → $5 | $1.05 | +376.19% | 1 | Jul 31, 2024 |
Evolent Health
Nov 17, 2025
Maintains: Overweight
Price Target: $13 → $7
Current: $2.21
Upside: +216.74%
HealthEquity
Sep 3, 2025
Maintains: Overweight
Price Target: $125 → $126
Current: $82.51
Upside: +52.71%
Veeva Systems
Aug 28, 2025
Maintains: Neutral
Price Target: $274 → $290
Current: $172.59
Upside: +68.03%
Progyny
Aug 26, 2025
Maintains: Neutral
Price Target: $23 → $25
Current: $17.27
Upside: +44.76%
Doximity
May 27, 2025
Maintains: Neutral
Price Target: $63 → $60
Current: $23.69
Upside: +153.27%
IQVIA Holdings
May 19, 2025
Maintains: Overweight
Price Target: $232 → $177
Current: $163.85
Upside: +8.03%
Omnicell
Mar 20, 2025
Maintains: Neutral
Price Target: $44 → $36
Current: $32.75
Upside: +9.92%
Phreesia
Sep 9, 2024
Maintains: Overweight
Price Target: $27 → $28
Current: $10.98
Upside: +155.01%
Consensus Cloud Solutions
Sep 9, 2024
Downgrades: Underweight
Price Target: $19 → $21
Current: $24.43
Upside: -14.04%
Health Catalyst
Sep 4, 2024
Maintains: Overweight
Price Target: $10 → $13
Current: $1.10
Upside: +1,081.82%
Aug 19, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $23.54
Upside: +14.70%
Jul 31, 2024
Downgrades: Underweight
Price Target: $7 → $5
Current: $1.05
Upside: +376.19%